SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 115 filers reported holding G1 THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.16 and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$226,000
-0.4%
18,100
-39.5%
0.00%0.0%
Q1 2022$227,000
-74.8%
29,910
-66.1%
0.00%
-83.3%
Q4 2021$902,000
+34.4%
88,330
+76.6%
0.02%
+100.0%
Q3 2021$671,000
-39.6%
50,020
+8.3%
0.01%
-36.8%
Q1 2021$1,111,00046,1800.02%
Other shareholders
G1 THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Birchview Capital, LP 120,000$172,8000.15%
DENALI ADVISORS LLC 148,800$214,2720.08%
XTX Topco Ltd 296,601$427,1050.07%
NEEDHAM INVESTMENT MANAGEMENT LLC 234,000$336,9600.06%
LEVEL FOUR ADVISORY SERVICES, LLC 183,400$264,0960.02%
Curi Wealth Management, LLC 70,742$101,8690.02%
FRANKLIN STREET ADVISORS INC /NC 83,400$1200.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 140,000$201,6000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 573,256$825,4890.01%
ALGERT GLOBAL LLC 68,100$980.01%
View complete list of G1 THERAPEUTICS INC shareholders